THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

What The Translational Genomics Research Institute does

The organization over time

Each line starts at 100 in 2018, so what you read is the shape rather than the size: 150 means half as much again as 2018, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2020 to 2021, from $140M to $224M (+60%).

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

Government-grant reliance: 2018 18% · 2019 9% · 2020 11% · 2021 6% · 2022 33% · 2023 35% · 2024 21% · 2025 38%. Grants only. Government contracts and fees sit inside program revenue.

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 8 reported years ran a deficit.

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Who funds it, year by year

2017 → 2023: the base broadened from 10 funders to 15 funders, grant income rose $1.3M → $2.8M.

9 of 52 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 17% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

Left out of every figure on this page: $215M from 4 payers (the payer shares this organization's board, largest City of Hope). These are real filings, and they are not money THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE raised.

From the IRS filings of THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE’s funders (the co-funder graph). Top 30 of 52 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE has a broad base — no single funder exceeds 16% of grant income, and it takes 6 funders to reach half.

91% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE.

Largest funder’s share by year: 2017 40% · 2018 34% · 2019 29% · 2020 59% · 2021 41% · 2022 21% · 2023 31% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

19% of THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE's funders are still giving 3 years after their first grant; 54% give in more than one year at all.

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE draws 74% of its grant income from funders outside Arizona, across 19 states in all.

Funder states come from each funder’s own filing. $3.0M arriving through sponsors registered in 8 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.